Generated by GPT-5-mini| Jaume Puigjaner | |
|---|---|
| Name | Jaume Puigjaner |
| Birth date | 1950s |
| Birth place | Barcelona, Spain |
| Fields | Biomedical engineering; Biomechanics; Tissue engineering |
| Workplaces | Universitat Politècnica de Catalunya; Universitat de Barcelona; Hospital Clínic de Barcelona |
| Alma mater | Universitat Politècnica de Catalunya; Imperial College London |
| Known for | Biomaterials; Cardiovascular biomechanics; Translational research |
Jaume Puigjaner is a Spanish biomedical engineer and translational researcher noted for contributions to biomaterials and cardiovascular biomechanics with clinical collaborations across Catalonia and Europe. His work integrates experimental mechanics, tissue engineering and device development with partnerships involving hospitals and technology transfer offices, influencing research agendas at institutions such as the Universitat Politècnica de Catalunya and the Universitat de Barcelona. Puigjaner has participated in EU Framework Programme projects, national research networks, and interdisciplinary consortia linking academic laboratories, clinical centres and industry.
Puigjaner was born in Barcelona and completed early studies in industrial and mechanical foundations at technical schools linked to the Universitat Politècnica de Catalunya and regional institutes in Catalonia. He proceeded to advanced training in biomechanical sciences and materials at institutions including the Imperial College London and research centres affiliated with the Consejo Superior de Investigaciones Científicas (CSIC). During graduate study he trained under senior investigators with ties to the Hospital Clínic de Barcelona and the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), combining laboratory biomechanics, polymer science and preclinical testing methodologies.
Puigjaner held faculty positions at the Universitat Politècnica de Catalunya and maintained joint appointments with the Universitat de Barcelona and clinical departments at the Hospital Clínic de Barcelona. He led laboratory groups that collaborated with research programmes funded by the European Commission, the Ministerio de Ciencia e Innovación and regional agencies in Catalonia. His teams worked closely with translational platforms such as the CIBER-BBN (Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina) and coordinated multicentre projects involving the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), the Barcelona Supercomputing Center and industrial partners from the European Medicines Agency-linked stakeholder networks. Puigjaner also served on advisory boards for doctoral schools at the Universitat de València and international committees organizing symposia at venues like the European Society of Biomechanics annual meeting.
Puigjaner's scientific contributions span experimental characterisation of soft tissues, biomaterial scaffold design and preclinical evaluation of cardiovascular devices. He published research on mechanical properties of vascular tissues comparing human specimens from the Hospital Universitari Germans Trias i Pujol with animal models such as porcine arteries used at the Centre de Recerca en Sanitat Animal (IRTA-CReSA). His work on polymeric scaffolds for tissue regeneration connected to collaborations with groups at the École Polytechnique Fédérale de Lausanne, the Max Planck Institute for Intelligent Systems and the Massachusetts Institute of Technology, evaluating cell–material interactions with expertise drawn from laboratories linked to the Wellcome Trust and the Human Frontier Science Program. Puigjaner contributed to standards and testing methodologies adopted by agencies like the European Committee for Standardization and advised clinical translation paths involving regulatory stakeholders such as the European Medicines Agency and national competent authorities. He fostered interdisciplinary training linking engineering students with clinicians from the Institut Català de la Salut and entrepreneurial teams supported by the European Institute of Innovation and Technology.
Puigjaner received recognitions from regional and national organisations for scientific and translational impact, including prizes awarded by the Generalitat de Catalunya and the Ministerio de Ciencia e Innovación. He was honoured with fellowships and invited professorships at institutions such as the Imperial College London and the École Polytechnique, and served as a member of scientific advisory boards for the CIBER network and the Fundació La Marató de TV3 grants panel. Professional societies including the European Society of Biomechanics and the Spanish Society of Biomechanics acknowledged his service with lifetime achievement-style citations and keynote invitations to major congresses.
- Puigjaner J., et al. Experimental characterisation of arterial biomechanics: comparative study of human and porcine models. Journal of Biomechanics; collaborating authors from Hospital Clínic de Barcelona, IDIBAPS and CIBER-BBN. - Puigjaner J., et al. Polymeric scaffold architectures for vascular tissue engineering: in vitro and in vivo evaluation. Biomaterials; partnership with teams at EPFL, MIT and Max Planck Institute. - Puigjaner J., et al. Standards for preclinical testing of cardiovascular implants: recommendations from a European consortium. Journal of Biomedical Materials Research; contributors from European Committee for Standardization, EMA and national competent authorities. - Puigjaner J., et al. Multiscale modelling of soft tissue mechanics integrating experimental data and computational frameworks. Computer Methods in Biomechanics and Biomedical Engineering; coauthors from Barcelona Supercomputing Center, Imperial College London and Universitat Politècnica de Catalunya.
Puigjaner is named inventor on patents and technology disclosures covering scaffold fabrication methods, bioresorbable polymer blends and device-design features aimed at improving vascular graft integration and durability. Several innovations were licensed to spin-offs incubated through the Barcelona Activa programme and technology transfer offices at the Universitat Politècnica de Catalunya and the Universitat de Barcelona. He participated in startup formation supported by accelerators linked to the European Institute of Innovation and Technology and in public–private partnership pilots involving medtech companies contracted through the Catalan Government procurement channels.
Category:Spanish biomedical engineers Category:Biomechanics researchers Category:People from Barcelona